SSKN News and Press, Strata Skin Sciences Inc. From 03/17/20

STRATA Skin Sciences (NASDAQ: SSKN ): Q4 GAAP EPS of -$0.02 in-line. More news on: STRATA Skin Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Recurring revenues grew 12.6% in 2019 Total gross margins increased 6.9% in 2019 Global recurring revenue installed base totaled 830 systems at year end 2019 Conference call and webcast, today at 8:30 am Eastern Time HORSHAM, Pa., March 17, 2020 (GLOBE NEWSWIRE) -- STRATA S...

HORSHAM, Pa., March 10, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for...

HORSHAM, Pa., Jan. 23, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for ...

Preliminary, unaudited fourth quarter revenues in the range of $8.8 million to $8.85 million Preliminary, unaudited fourth quarter recurring revenues in the range of $6.5 million to $6.55 million Preliminary, unaudited fourth quarter revenues result in double digit growth Dom...

Successfully extinguishes existing debt with a new commercial bank loan facility New fixed annual interest rate of 2.79%, reduces interest rate costs by approximately $700,000 HORSHAM, Pa., Jan. 06, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRAT...

HORSHAM, Pa., Nov. 19, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for ...

Company recurring revenue segment revenue up 13% for the nine months ended September 30, 2019 over comparable period in 2018 Company recurring revenue segment gross margins for the nine months ended September 30, 2019 and 2018 were 68.0% and 62.5%, respectively Company generated ...

HORSHAM, Pa., Nov. 14, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditio...

STRATA Skin Sciences, Inc. (SSKN) Business Update Conference Call October 30, 2019, 8:30 AM ET Company Participants Matthew Picciano - IR, LifeSci Advisors Dolev Rafaeli - Chief Executive Officer Matthew Hill - Chief Financial Officer Conference Call Participants Jeffrey Co...